We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Slaps Sun Pharma With Form 483 for Allegedly Falsifying Documents
FDA Slaps Sun Pharma With Form 483 for Allegedly Falsifying Documents
Indian generic drugmaker Sun Pharmaceuticals drew an FDA Form 483 for allegedly falsifying internal documents covering batch records, among other deficiencies, following an agency inspection of the company’s plant in Mohali, Punjab, from Aug. 3 to 12.